Iluzanebart Human Monoclonal Antibody
Iluzanebartis a research-grade recombinant antibody targeting Triggering receptor expressed on myeloid cells 2. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
Triggering receptor expressed on myeloid cells 2, Triggering receptor expressed on monocytes 2, TREM-2, TREM2
UniProt
Q9NZC2
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG1-kappa
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CSRP2 Polyclonal Antibody, AbBy Fluor™ 350 Conjugated
HSPA7, ID (Heat Shock 70kD Protein B, Putative Heat Shock 70kD Protein 7, HSP70B) (MaxLight 650) discontinued
AFF4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)